公司概覽
業務類別 Biotechnology
業務概覽 Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
公司地址 825 Industrial Road, Suite 100, San Carlos, CA, USA, 94070
電話號碼 +1 650 260-7120
傳真號碼 --
公司網頁 https://www.iovance.com
員工數量 975
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Igor P. Bilinsky, PhD Chief Operating Officer 美元 551.24K 28/04/2025
Mr. Daniel Gordon Kirby Chief Commercial Officer -- 28/04/2025
Dr. Frederick G. Vogt, J.D. Director, General Counsel, Interim Chief Executive Officer and President 美元 730.06K 24/02/2026
Ms. Corleen M. Roche Chief Financial Officer and Principal Accounting Officer -- 24/02/2026
Dr. Friedrich Graf Finckenstein, M.D. Chief Medical Officer 美元 612.11K 28/04/2025
Dr. Raj K. Puri, M.D. Chief Regulatory Officer -- 28/04/2025
Mr. Matthew Rosinack Senior Vice President, Finance -- 15/07/2025
 
董事會成員
董事會 職務 更新日期
Dr. Michael Weiser,M.D.,PhD Independent Director 24/02/2026
Mr. Ryan D. Maynard Independent Director 24/02/2026
Dr. Athena Countouriotis, M.D. Independent Director 24/02/2026
Mr. Wayne P. Rothbaum Independent Director 24/02/2026
Dr. Iain D. Dukes, D.Phil. Non-Executive Chairman of the Board 24/02/2026
Dr. Frederick G. Vogt, J.D. Director, General Counsel, Interim Chief Executive Officer and President 24/02/2026
Ms. Wendy L. Yarno, M.B.A. Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:05)
代號 名稱 佔比% 持有日期
XBIState Street® SPDR® S&P® Biotech ETF2.84%27/02/2026
IWNiShares Russell 2000 Value ETF0.64%28/02/2026
IBBiShares Biotechnology ETF0.60%28/02/2026
SCHASchwab US Small-Cap ETF™0.39%28/02/2026
VTWOVanguard Russell 2000 ETF0.36%31/01/2026
KOMPStt Strt®SPDR®S&PKenshoNwEcosComposETF0.32%27/02/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.26%27/02/2026
VHTVanguard Health Care ETF0.23%31/01/2026
DFASDimensional US Small Cap ETF0.19%27/02/2026
HQLabrdn Life Sciences Investors0.18%31/01/2026
IDNAiShares Genomics Immnlgy & Hlthcr ETF0.13%28/02/2026
LABUDirexion Daily S&P Biotech Bull 3X ETF0.12%26/02/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.10%28/02/2026
BBPVirtus LifeSci Biotech Products ETF0.08%27/02/2026
SCHBSchwab US Broad Market ETF™0.05%28/02/2026
VTWVVanguard Russell 2000 Value ETF0.05%31/01/2026
AVSCAvantis US Small Cap Equity ETF0.05%28/02/2026
ONEQFidelity Nasdaq Composite ETF0.04%27/02/2026
FHLCFidelity MSCI Health Care ETF0.03%28/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.02%27/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.